Synthesis and assessment of the cytotoxic effect of some of 1,4-dihydropyridine derivatives which contain azole moiety Scientific paper

Main Article Content

Saeed Ghorbannejad
Karim Akbari Dilmaghani
https://orcid.org/0000-0002-0084-3580
Abbas Nikoo
https://orcid.org/0000-0002-0021-7475

Abstract

A number of 1,4-dihydropyridine derivatives (9ad, 10ad and 11ad) were designed and synthesized by the reaction of 1,3,4-oxadiazole-5-thiones and 1,2,4-triazole-5-thiones to 2,6-dibromomethyl-3,5-diethoxycarbonyl-4-(3-ni­tro­phenyl)-1,4-dihydropyridine. The synthesized compounds were charac­terized using FT-IR, 1H-NMR, 13C-NMR spectral data, ESI-MS and elemental analysis. The cytotoxicity of the synthesized compounds was evaluated in human breast cancer (MCF-7) cells based on the results of MTT assay. The results indicated that compound diethyl 4-(3-nitrophenyl)-2,6-bis[((5-(3-nitro­phenyl)-1,3,4-oxa­di­azol-2-yl)thio)methyl]-1,4-dihydro pyridine-3,5-dicarbo­xylate (9b) with (IC50 = 23±2.32 µM) was the most potent derivative against MCF-7 cells. Based on the results, the use of oxadiazole moiety in the C2 and C6 positions of 1,4-di­hyd­ropyridine ring system enhanced the cytotoxic potential of these der­ivatives. Therefore, some of the oxadiazole-substituted 1,4-DHPs may facilitate further modifications which result in the discovery of potent cytotoxic agents.

Article Details

How to Cite
[1]
S. Ghorbannejad, K. Akbari Dilmaghani, and A. Nikoo, “Synthesis and assessment of the cytotoxic effect of some of 1,4-dihydropyridine derivatives which contain azole moiety: Scientific paper”, J. Serb. Chem. Soc., vol. 86, no. 11, pp. 1013-1021, Nov. 2021.
Section
Organic Chemistry

References

D. J. Triggle, Biochem. Pharmacol. 74 (2007) 1 (http://dx.doi.org/10.1016/j.bcp.2007.01.016)

C. Bladen, M. G. Gündüz, R. Şimşek, C. Şafak, G. W. Zamponi, Pflugers Arch – Eur. J. Physiol. 466 (2014) 1355 (http://dx.doi.org /10.1007/s00424-013-1376-z)

R. Bansal, G. Narang, C. Calle, R. Carron, K. Pemberton, A. L. Harvey, Drug Dev. Res. 74 (2013) 50 (http://dx.doi.org/10.1002/ddr.21056)

N. Razzaghi-Asl, R. Miri, O. Firuzi, Iran. J. Pharm. Sci. 15 (2016) 413 (http://dx.doi.org/10.22037/IJPR.2016.1870)

A. Ahamed, I. A. Arif, M. Mateen, R. S. Kumar, A. Idhayadhull, Saudi J. Biol. Sci. 25 (2018) 1227 (http://dx.doi.org/10.1016/j.sjbs.2018.03.001)

J. Marín-Prida, G. L. P. Andreu, C. P. Rossignoli, M. G. Durruthy, E. O. Rodríguez, Y. V. Reyes, R. F. Acosta, S. A. Uyemura, L. C. Alberici, Toxicol. In Vitro 42 (2017) 21 (http://dx.doi.org/10.1016/j.tiv.2017.03.011)

D. Viradiya, S. Mirza, F. Shaikh, R. Kakadiya, A. Rathod, N. Jain, R. Rawal, A. Shah, Anticancer Agents Med. Chem. 17 (2017) 1003 (http://dx.doi.org/10.2174/1871520616666161206143251)

F. Shekari, H. Sadeghpour, K. Javidnia, L. Saso, F. Nazari, O. Firuzi, R. Miri, Eur. J. Pharmacol. 746 (2015) 233 (http://dx.doi.org/10.1016/j.ejphar.2014.10.058)

S. Tasaka, H. Ohmori, N. Gomi, M. Iino, T. Machida, A. Kiue, S. Naito, M. Kuwano, Bioorganic Med. Chem. Lett. 11 (2001) 275 (http://dx.doi.org/10.1016/S0960-894X(00)00651-X)

H. Engi, H. Sakagami, M. Kawase, A. Parecha, D. Manvar, H. Kothari, P. Adlakha, A. Shah, N. Motohashi, I. Ocsovszki, J. Molnar, In Vivo 20 (2006) 637 (https://www.researchgate.net/publication/6705056)

M. F. Mohamed, A. F. Darweesh, A. H. M. Elwahy, I. A. Abdelhamid, RSC Adv. 6 (2016) 40900 (http://dx.doi.org/10.1039/c6ra04974e)

O. Firuzi, K. Javidnia, E. Mansourabadi, L. Saso, A.R. Mehdipour, R. Miri, Arch. Pharm. Sci. Res. 36 (2013) 1392 (http://dx.doi.org/10.1007/s12272-013-0149-8)

M. G. Pavani, M. Nunez, P. Brigidi, B. Vitali, R. Gambari, Bioorg. Med. Chem. 10 (2002) 449 (http://dx.doi.org/10.1016/S0968-0896(01)00294-2)

R. Miri, A. Mehdipour, Bioorg. Med. Chem. 16 (2008) 8329 (http://dx.doi.org/10.1016/j.bmc.2008.07.025)

A. Zarrin, A. R. Mehdipour, R. Miri, Chem. Biol. Drug. Des. 76 (2010) 369 (http://dx.doi.org/10.1111/j.1747-0285.2010.01025.x)

J. R. Warr, F. Brewer, M. Anderson, J. Fergusson, Cell Biol. Int. Rep. 10 (1986) 389 (http://dx.doi.org/10.1016/0309-1651(86)90011-1)

T. Tsuruo, H. Kawabata, N. Nagumo, H. lida, Y. Kitatani, S. Tsukagoshi, Y. Sakurai, Cancer Chemother. Pharmacol. 15 (1985) 16 (http://dx.doi.org/10.1007/BF00257287)

T. Godfraind, J. Cardiovasc. Pharmacol. Ther. 19 (2014) 501 (http://dx.doi.org/10.1177/1074248414530508)

B. Laupeze, L. Amiot, N. Bertho, J. M. Grosset, G. Lehne, R. Fauchet, O. Fardel, Hum. Immunol. 62 (2001) 1073 (http://dx.doi.org/10.1016/S0198-8859(01)00307-X)

R. Surendrakumar, A. Manilal, A. J. Abdul Nasser, B. Merdekios, X. Chen, A. Idhayadhulla, J. Pharmacol. Toxicol. 9 (2014) 119 (https://dx.doi.org/10.3923/jpt.2014.119.128 )

A. B. Archana, D. R. Dinesh, S. G. Paraag, Y. S. Prabhakar, Int. J. Pharm. Chem. 4 (2014) 62 (http://dx.doi.org/10.7439/ijpc.v4i2.75)

M. Ziaie, K. Akbari Dilmaghani, A. Tukmechi, Acta Chim. Slov. 64 (2017) 895 (http://dx.doi.org/10.17344/acsi.2017.3506)

R. M. Shaker, ARKIVOC IX (2006) 59 (https://dx.doi.org/10.3998/ark.5550190.0007.904)

A. A. Aly, A. A. Hassan, M. M. Makhlouf, S. Brase, Molecules 25 (2020) 3036 (http://dx.doi.org/10.3390/molecules25133036)

A. A. Othman, M. Kihel, S. Amara, Arab. J. Chem. 12 (2019) 1660 (http://dx.doi.org/10.1016/j.arabjc.2014.09.003)

K. M. Dawood, A. M. Farag, H. A. Abdel-Aziz, Heteroat. Chem. 16 (2005) 621 (http://dx.doi.org/10.1002/hc.20162)

J. Shneine, Y. H. Alaraji, IJSR 5 (2016) 1411 (https://www.ijsr.net/get_abstract.php?paper_id=NOV161902)

S. D. Bajaj, O. A. Mahodaya, P. V. Tekade, V. B. Patil, S. D. Kukade, Russ. J. Gen. Chem. 87 (2017) 546 (http://dx.doi.org/10.1134/S1070363217030264)

V. Palermo, A. G. Sathicq, T. Constantieux, J. Rodriguez, P. G. Vazquez, G. P. Romanelli, Catal. Lett. 146 (2016) 1634 (http://dx.doi.org/10.1007/s10562-016-1784-8)

D. Viradiya, S. Mirza, F. Shaikh, R. Kakadiya, A. Rathod, N. Jain, R. Rawal, A. Shah, Anti-Cancer Agents Med. Chem. 17 (2017) 1003 (http://dx.doi.org/10.2174/1871520616666161206143251)

N. Razzaghi-Asl, R. Miri, O. Firuzi, Iran. J. Pharm. Res. 15 (2016) 413 (http://dx.doi.org/10.22037/ijpr.2016.1870)

R. Surendra kumar, A. Idhayadhulla, A. Jamal Abdul Nasser, K. Murali, Indian J. Chem., B 50 (2011) 1140 (http://nopr.niscair.res.in/handle/123456789/12520)

R. Sarkhosh Inanlou, M. Molaparast, A. Mohammadzadeh, V. Shafiei Irannejad, Chem. Biol. Drug. Des. 95 (2019) 215 (http://dx.doi.org/10.1111/cbdd.13621)

K. H. Chikhalia, D. B. Vashi, M. J. Patel, J. Enzyme Inhib. Med. Chem. 24 (2009) 617 (http://dx.doi.org/10.1080/14756360802318936)

M. Petrova, R. Muhamadejev, B. Vigante, B. Cekavicus, A. Plotniece, G. Duburs, E. Liepinsh, Molecules 16 (2011) 8041 (http://dx.doi.org/10.3390/molecules16098041).